Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1993 Mar;67(3):635–637. doi: 10.1038/bjc.1993.116

Female hormone utilisation and risk of hepatocellular carcinoma.

A Tavani 1, E Negri 1, F Parazzini 1, S Franceschi 1, C La Vecchia 1
PMCID: PMC1968244  PMID: 8382515

Abstract

The relationship between female hormone use and primary liver cancer was analysed using data from a case-control study conducted between 1984 and 1992 in Milan on 82 female incident cases with histologically or serologically confirmed hepatocellular carcinoma and 368 controls admitted to hospital for acute non-neoplastic, non-hormone-related diseases. An elevated relative risk (RR) or primary liver cancer was observed in oral contraceptive (OC) users (RR 2.6, for ever versus never users, 95% confidence interval, CI 1.0-7.0). The RR was directly related to duration of use (RR 1.5 for < or = 5 years and 3.9 for > 5 years) and persisted for longer than 10 years after stopping use (RR 4.3%, 95% CI 1.0-18.2). The RR were below unity, although not significantly, for women ever using oestrogen replacement therapy (RR 0.2, 95% CI 0.03-1.5) and female hormones for indications other than contraception and menopausal therapy (RR 0.4, 95% CI 0.1-1.5). The long-lasting, association between risk of hepatocellular carcinoma and OC use has potential implications on a public health scale, since primary liver cancer is a relatively rare disease among young women, but much more common at older ages. This study provides limited but reassuring evidence on the possible relationship between oestrogen replacement treatment and subsequent risk of hepatocellular carcinoma.

Full text

PDF
635

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adami H. O., Persson I., Hoover R., Schairer C., Bergkvist L. Risk of cancer in women receiving hormone replacement therapy. Int J Cancer. 1989 Nov 15;44(5):833–839. doi: 10.1002/ijc.2910440515. [DOI] [PubMed] [Google Scholar]
  2. Baum J. K., Bookstein J. J., Holtz F., Klein E. W. Possible association between benign hepatomas and oral contraceptives. Lancet. 1973 Oct 27;2(7835):926–929. doi: 10.1016/s0140-6736(73)92594-4. [DOI] [PubMed] [Google Scholar]
  3. Decarli A., La Vecchia C. Cancer mortality in Italy, 1955-78. Tumori. 1984 Dec 31;70 (Suppl):581–742. doi: 10.1177/03008916840706s101. [DOI] [PubMed] [Google Scholar]
  4. Forman D., Vincent T. J., Doll R. Cancer of the liver and the use of oral contraceptives. Br Med J (Clin Res Ed) 1986 May 24;292(6532):1357–1361. doi: 10.1136/bmj.292.6532.1357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Henderson B. E., Preston-Martin S., Edmondson H. A., Peters R. L., Pike M. C. Hepatocellular carcinoma and oral contraceptives. Br J Cancer. 1983 Sep;48(3):437–440. doi: 10.1038/bjc.1983.210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hsing A. W., Hoover R. N., McLaughlin J. K., Co-Chien H. T., Wacholder S., Blot W. J., Fraumeni J. F., Jr Oral contraceptives and primary liver cancer among young women. Cancer Causes Control. 1992 Jan;3(1):43–48. doi: 10.1007/BF00051911. [DOI] [PubMed] [Google Scholar]
  7. La Vecchia C., Franceschi S., Bruzzi P., Parazzini F., Boyle P. The relationship between oral contraceptive use, cancer and vascular disease. Drug Saf. 1990 Nov-Dec;5(6):436–446. doi: 10.2165/00002018-199005060-00004. [DOI] [PubMed] [Google Scholar]
  8. La Vecchia C., Negri E., Decarli A., D'Avanzo B., Franceschi S. A case-control study of diet and gastric cancer in northern Italy. Int J Cancer. 1987 Oct 15;40(4):484–489. doi: 10.1002/ijc.2910400409. [DOI] [PubMed] [Google Scholar]
  9. La Vecchia C., Negri E., Decarli A., D'Avanzo B., Franceschi S. Risk factors for hepatocellular carcinoma in northern Italy. Int J Cancer. 1988 Dec 15;42(6):872–876. doi: 10.1002/ijc.2910420614. [DOI] [PubMed] [Google Scholar]
  10. La Vecchia C., Negri E., Parazzini F. Oral contraceptives and primary liver cancer. Br J Cancer. 1989 Mar;59(3):460–461. doi: 10.1038/bjc.1989.94. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. MANTEL N., HAENSZEL W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959 Apr;22(4):719–748. [PubMed] [Google Scholar]
  12. Mettlin C., Natarajan N. Studies on the role of oral contraceptive use in the etiology of benign and malignant liver tumors. J Surg Oncol. 1981;18(1):73–85. doi: 10.1002/jso.2930180112. [DOI] [PubMed] [Google Scholar]
  13. Neuberger J., Forman D., Doll R., Williams R. Oral contraceptives and hepatocellular carcinoma. Br Med J (Clin Res Ed) 1986 May 24;292(6532):1355–1357. doi: 10.1136/bmj.292.6532.1355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Palmer J. R., Rosenberg L., Kaufman D. W., Warshauer M. E., Stolley P., Shapiro S. Oral contraceptive use and liver cancer. Am J Epidemiol. 1989 Nov;130(5):878–882. doi: 10.1093/oxfordjournals.aje.a115420. [DOI] [PubMed] [Google Scholar]
  15. Stanford J. L., Thomas D. B. Reproductive factors in the etiology of hepatocellular carcinoma. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Cancer Causes Control. 1992 Jan;3(1):37–42. doi: 10.1007/BF00051910. [DOI] [PubMed] [Google Scholar]
  16. Trichopoulos D. Etiology of primary liver cancer and the role of steroidal hormones. Cancer Causes Control. 1992 Jan;3(1):3–5. doi: 10.1007/BF00051905. [DOI] [PubMed] [Google Scholar]
  17. Tzonou A., Zavitsanos X., Hsieh C. C., Trichopoulos D. Liveborn children and risk of hepatocellular carcinoma. Cancer Causes Control. 1992 Mar;3(2):171–174. doi: 10.1007/BF00051657. [DOI] [PubMed] [Google Scholar]
  18. Yager J. D., Jr, Yager R. Oral contraceptive steroids as promoters of hepatocarcinogenesis in female Sprague-Dawley rats. Cancer Res. 1980 Oct;40(10):3680–3685. [PubMed] [Google Scholar]
  19. Yu M. C., Tong M. J., Govindarajan S., Henderson B. E. Nonviral risk factors for hepatocellular carcinoma in a low-risk population, the non-Asians of Los Angeles County, California. J Natl Cancer Inst. 1991 Dec 18;83(24):1820–1826. doi: 10.1093/jnci/83.24.1820. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES